These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17049832)
1. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. Tang FY; Chiang EP; Shih CJ J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832 [TBL] [Abstract][Full Text] [Related]
2. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Tang FY; Nguyen N; Meydani M Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064 [TBL] [Abstract][Full Text] [Related]
4. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757 [TBL] [Abstract][Full Text] [Related]
5. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163 [TBL] [Abstract][Full Text] [Related]
7. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364 [TBL] [Abstract][Full Text] [Related]
8. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246 [TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs. Piyaviriyakul S; Shimizu K; Asakawa T; Kan T; Siripong P; Oku N Biol Pharm Bull; 2011; 34(3):396-400. PubMed ID: 21372391 [TBL] [Abstract][Full Text] [Related]
10. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451 [TBL] [Abstract][Full Text] [Related]
11. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Kondo T; Ohta T; Igura K; Hara Y; Kaji K Cancer Lett; 2002 Jun; 180(2):139-44. PubMed ID: 12175544 [TBL] [Abstract][Full Text] [Related]
12. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556 [TBL] [Abstract][Full Text] [Related]
13. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Wang J; Man GCW; Chan TH; Kwong J; Wang CC Cancer Lett; 2018 Jan; 412():10-20. PubMed ID: 29024813 [TBL] [Abstract][Full Text] [Related]
14. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. Sartippour MR; Shao ZM; Heber D; Beatty P; Zhang L; Liu C; Ellis L; Liu W; Go VL; Brooks MN J Nutr; 2002 Aug; 132(8):2307-11. PubMed ID: 12163680 [TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase. Guo BC; Wei J; Su KH; Chiang AN; Zhao JF; Chen HY; Shyue SK; Lee TS Mol Nutr Food Res; 2015 Apr; 59(4):646-57. PubMed ID: 25581901 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861 [TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120 [TBL] [Abstract][Full Text] [Related]
18. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Annabi B; Lee YT; Martel C; Pilorget A; Bahary JP; Béliveau R Cancer Biol Ther; 2003; 2(6):642-9. PubMed ID: 14688468 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells. Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903 [TBL] [Abstract][Full Text] [Related]
20. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]